Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare...
-
Quarterly Dividend Increased 7.7% to $0.07 Per Share MINNEAPOLIS, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of...
-
WALL, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions,...
-
TULSA, Okla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- BOK Financial Corporation (NASD: BOKF) - CEO Commentary Steven G. Bradshaw, president and chief executive officer, stated, “The third quarter...
-
MIAMI BEACH, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”), an industry leader and national provider of body contouring procedures delivering a premium consumer...
-
BANNOCKBURN, Ill., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”) announced today that it intends to offer $500 million in...
-
BANNOCKBURN, Ill., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”), the nation’s largest independent provider of home and...
-
BEIJING, Oct. 20, 2021 (GLOBE NEWSWIRE) -- ZW Data Action Technologies, Inc. (Nasdaq: CNET) ("ZW Data" or the "Company"), an integrated online advertising, precision marketing, data analytics, and...
-
First preclinical data demonstrating Intellia’s allogeneic platform creates immune-evading T cells for therapeutic use in future cancer treatmentsDemonstrated lipid nanoparticle-based delivery as a...
-
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...